Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Compare ongoing fees across top dividend ETFs for 2024 to find the funds with the lowest drag on your returns and best value.
28,084 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Arista Networks and AudioCodes sit at different points in the networking landscape. This article breaks down their bu...
Robert Kiyosaki says he bought more BTC, doubling down on a view that bitcoin could eventually outperform gold amid m...
Oracle posted stronger-than-expected cloud results for Q3 FY2026, sending ORCL higher and helping the stock lead tech...
Citi has joined a growing chorus of concerns around Super Micro Computer, trimming its price target to $25 amid expor...
Investors are eyeing aemetis (amtx) 2025 earnings as the company advances its biofuels and biochemicals projects. Thi...
By 2026, European DST policies are still pressing issues for tech giants and online platforms. This guide breaks down...
A unique look at a troubling scam where an elderly woman lost a fortune after an Amazon account scare. This guide bre...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
A tiny pre-IPO tech winner is closing its round for retail investors as millions log hours in VR workspaces. Here’s w...
Nike faces a pivotal few years as it shifts toward direct-to-consumer and digital growth. This deep dive outlines whe...
Walmart beat Q4 estimates on earnings and revenue but guided FY27 growth below consensus, sparking bearish chatter fr...